Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...
Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.
AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
emphasizing Vertex (VRTX), Amgen (AMGN), and Gilead (GILD) as some of his top large-cap picks in the sector. To watch more expert insights and analysis on the latest market action, check out more ...
Vertex Pharmaceuticals Incorporated (NASDAQ ... Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation. This isn’t just about making money ...
Hakimo has raised $10.5 million of Series A funding as it continues to scale up and develop its AI-powered security guarding ...
USA News Group News Commentary – Artificial intelligence is rapidly transforming the healthcare sector, with adoption of AI ...
Google has unveiled Gemini 2.5 Pro, calling it its “most intelligent AI model” to date. This latest large language model, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results